[HTML][HTML] Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …
human papillomavirus (HPV) is currently the most common pathogen responsible for female …
HPV self-sampling for cervical cancer screening: a systematic review of values and preferences
Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …
an additional screening method and HPV DNA testing as an effective approach for the early …
[HTML][HTML] Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3 …
PK Pretsch, LP Spees, NT Brewer… - The Lancet Public …, 2023 - thelancet.com
Background Most cervical cancer in the USA occurs in under-screened women. The My
Body, My Test-3 (MBMT-3) trial sought to assess the efficacy of mailed human …
Body, My Test-3 (MBMT-3) trial sought to assess the efficacy of mailed human …
Coupling CRISPR/Cas12a and recombinase polymerase amplification on a stand-alone microfluidics platform for fast and parallel nucleic acid detection
Timely identification of human papillomavirus (HPV) infection is crucial for the prevention of
cervical cancer. Current HPV detection methods mainly rely on polymerase chain reaction …
cervical cancer. Current HPV detection methods mainly rely on polymerase chain reaction …
[HTML][HTML] A framework for cervical cancer elimination in low-and-middle-income countries: a scoping review and roadmap for interventions and research priorities
The World Health Organization announced an ambitious call for cervical cancer elimination
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …
worldwide. With existing prevention and treatment modalities, cervical cancer elimination is …
[HTML][HTML] Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis
D Chu, T Liu, Y Yao - Frontiers in Microbiology, 2023 - frontiersin.org
Background Uterine Cervical Carcinoma (UCC) is the most prevalent gynecological
malignancy globally, with a rising incidence in recent years. Accumulating evidence …
malignancy globally, with a rising incidence in recent years. Accumulating evidence …
Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women …
D Ørnskov, K Jochumsen, PH Steiner, IM Grunnet… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To increase effectiveness of the cervical cancer screening program, self-
sampling can be an option. Both self-collected vaginal samples (SCV) and urine samples …
sampling can be an option. Both self-collected vaginal samples (SCV) and urine samples …
Acceptability of self‐taken vaginal HPV sample for cervical screening among an under‐screened Indigenous population
A Adcock, F Cram, B Lawton, S Geller… - Australian and New …, 2019 - Wiley Online Library
Background Human papillomavirus (HPV), the causative agent of cervical cancer, can be
screened for using self‐collected vaginal samples (self‐testing). This may overcome barriers …
screened for using self‐collected vaginal samples (self‐testing). This may overcome barriers …
[HTML][HTML] Comparison of different self-sampling devices for molecular detection of human papillomavirus (HPV) and other sexually transmitted infections (STIs): a pilot …
I Sechi, CE Cocuzza, M Martinelli, N Muresu… - Healthcare, 2022 - mdpi.com
Background: Cervical cancer is the fourth most common cancer in women, and it is well
known that high-risk human papillomavirus (hrHPV) infections are the necessary …
known that high-risk human papillomavirus (hrHPV) infections are the necessary …
Advances in technologies for cervical cancer detection in low-resource settings
Introduction: Cervical cancer mortality rates remain high in low-and middle-income countries
(LMICs) and other medically underserved areas due to challenges with implementation and …
(LMICs) and other medically underserved areas due to challenges with implementation and …